Rick Zhang

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple ...

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Rela...

MRD als intermediair klinisch eindpunt bij hematologische maligniteiten: EVIDENCE meta-analyse